BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Artificial Intelligence

NEC and Chugai Harness AI to Halve Time Needed for Predicting Effective Cancer Drug Combinations

Identified the potential to reduce the time required to research and predict drug combinations by approximately 50% NEC Corporation (NEC; TSE: ...

June 19, 2025 | News

VSA Signs LOI to Acquire HopeAI, Advancing Entry into AI-Driven Clinical Development

TCTM Kids IT Education Inc. (Nasdaq: VSA) (the "Company" or "VSA") today announced that it has entered into a non-binding letter of intent ("LOI") to acqui...

June 18, 2025 | News

66 Percent of APAC Patients Face Specialist Delays as Philips Urges Trust in AI to Ease Healthcare Pressures

66% of patients surveyed in APAC are experiencing delays in seeing specialist doctor, with an average waiting time of 47 days 89% of healt...

June 13, 2025 | Report

Deep Apple Therapeutics and Novo Nordisk Join Forces to Develop Next-Gen Oral Therapies for Cardiometabolic Diseases

- Deep Apple Therapeutics Announces Collaboration with Novo Nordisk to Discover and Develop Oral Therapies for Cardiometabolic Diseases The partnership ai...

June 12, 2025 | News

Insilico Medicine and AWS Bring Nach01 Generative AI Model for Drug Discovery to Global Researchers via AWS Marketplace

Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), announced the recent release of its Nach...

June 11, 2025 | News

RevolKa Secures $1.4M in Series A Extension to Advance AI-Driven Rare Disease Drug Discovery

RevolKa Ltd. (RevolKa), a venture-backed biotech company providing a cutting-edge AI-driven protein engineering technology platform called aiProtein&r...

May 21, 2025 | News

Lunit Expands U.S. Footprint with AI-Powered Breast Cancer Screening at Over 200 Sites

Building on Volpara's breast health expertise, Lunit strengthens its U.S. presence—now delivering AI-powered breast cancer screening across 200 imagi...

May 20, 2025 | News

BoomerangFX Launches LeadEngineAI™ Featuring AUVIA™ Across North America, Europe, and Asia-Pacific to Transform Patient Acquisition in Private Healthcare Clinics

BoomerangFX, the leading AI-powered SaaS platform for private-pay healthcare clinics, announced the global launch of LeadEngineAI™, a transform...

May 19, 2025 | News

NEC and Chugai Harness AI to Halve Time Needed for Predicting Effective Cancer Drug Combinations

VSA Signs LOI to Acquire HopeAI, Advancing Entry into AI-Driven Clinical Development

66 Percent of APAC Patients Face Specialist Delays as Philips Urges Trust in AI to Ease Healthcare Pressures

Deep Apple Therapeutics and Novo Nordisk Join Forces to Develop Next-Gen Oral Therapies for Cardiometabolic Diseases

Insilico Medicine and AWS Bring Nach01 Generative AI Model for Drug Discovery to Global Researchers via AWS Marketplace

RevolKa Secures $1.4M in Series A Extension to Advance AI-Driven Rare Disease Drug Discovery

Lunit Expands U.S. Footprint with AI-Powered Breast Cancer Screening at Over 200 Sites

BoomerangFX Launches LeadEngineAI™ Featuring AUVIA™ Across North America, Europe, and Asia-Pacific to Transform Patient Acquisition in Private Healthcare Clinics

Viva Biotech Unveils Advanced AI-Driven Drug Discovery Platform, Pioneering a New Era of Intelligent Therapeutics

iotaMotion Marks International Milestone with First Use of iotaSOFT® System in Zurich Cochlear Implant Study

QIAGEN Acquires Genoox to Boost AI-Driven Genomic Interpretation for Clinical Labs Globally

Benchling Expands Collaboration with Moderna to Power AI-Driven R&D Across Research Organization

Fangzhou Launches Otsuka’s Iclusig® Online for Leukemia Care in China

HistoIndex Raises S$9M to Accelerate AI-Powered Digital Pathology and Launch of FibroSIGHT™

Stay Connected